We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£80.65
Springer Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)
Price data last checked 13 day(s) ago - will refresh soon
We'll watch every seller, every day. One email when your price arrives.
This is the most expensive it has ever been. Walk away.
£81 today · previous high £81 · all-time low £80
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 78 days · 78 data points (no recent data)
Price Distribution
Price distribution over 78 days • 2 price levels
Price Analysis
Most common price: £81 (74 days, 94.9%)
Price range: £80 - £81
Price levels: 2 different prices over 78 days
Description
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 3319888919
- Domain
- Amazon UK
- Release Date
- 23 June 2018
- Listed Since
- 25 June 2018
Barcode
No barcode data available
Similar Products You Might Like
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
Springer
Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy)
Springer
Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy)
Springer
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
Springer
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
Springer
Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)
Springer
Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance
Elsevier
Triple-Negative Breast Cancer: A Clinician’s Guide
Springer
Prognostic variables in node-negative and node-positive breast cancer
Springer
A Practical Guide to Breast Cancer Treatment
Springer
Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects
Springer
Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)
Springer
Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)
Springer
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
Springer
Molecular Targeted Therapy of Lung Cancer
Springer
The Future of Prevention and Treatment of Breast Cancer
Springer
Early Onset Breast Cancer: Epidemiology, Pathobiology, Diagnosis, Treatment, and Survivorship
Springer
Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy
Springer
Emerging Therapeutic Targets in Ovarian Cancer
Springer
Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook
Springer
Endocrine Therapy of Breast Cancer VI (ESO Monographs)
Springer
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
Springer
Nutraceuticals and Cancer
Springer
Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)
Springer